186 related articles for article (PubMed ID: 22442271)
1. Impact of hyperglycemia on neuropathological alterations during critical illness.
Sonneville R; den Hertog HM; Güiza F; Gunst J; Derese I; Wouters PJ; Brouland JP; Polito A; Gray F; Chrétien F; Charlier P; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
J Clin Endocrinol Metab; 2012 Jun; 97(6):2113-23. PubMed ID: 22442271
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice.
Sonneville R; Derese I; Marques MB; Langouche L; Derde S; Chatre L; Chrétien F; Annane D; Sharshar T; Van den Berghe G; Vanhorebeek I
Shock; 2015 Sep; 44(3):245-51. PubMed ID: 26009823
[TBL] [Abstract][Full Text] [Related]
3. FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival.
Thiessen SE; Vanhorebeek I; Derese I; Gunst J; Van den Berghe G
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1319-27. PubMed ID: 26274346
[TBL] [Abstract][Full Text] [Related]
4. Increasing glucose load while maintaining normoglycemia does not evoke neuronal damage in prolonged critically ill rabbits.
Sonneville R; den Hertog HM; Derde S; Güiza F; Derese I; Van den Berghe G; Vanhorebeek I
Clin Nutr; 2013 Dec; 32(6):1077-80. PubMed ID: 23352270
[TBL] [Abstract][Full Text] [Related]
5. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
6. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
[TBL] [Abstract][Full Text] [Related]
7. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
Langouche L; Mesotten D; Vanhorebeek I
Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
[TBL] [Abstract][Full Text] [Related]
8. Intensive insulin therapy for critically ill patients.
Lewis KS; Kane-Gill SL; Bobek MB; Dasta JF
Ann Pharmacother; 2004; 38(7-8):1243-51. PubMed ID: 15187219
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients.
Vanhorebeek I; Gunst J; Derde S; Derese I; Boussemaere M; D'Hoore A; Wouters PJ; Van den Berghe G
J Clin Endocrinol Metab; 2012 Jan; 97(1):E59-64. PubMed ID: 22013100
[TBL] [Abstract][Full Text] [Related]
10. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
[TBL] [Abstract][Full Text] [Related]
11. [Hyperglycemia and mortality in critically ill children].
Mikos B; Barkai L
Orv Hetil; 2007 Apr; 148(15):683-8. PubMed ID: 17416576
[TBL] [Abstract][Full Text] [Related]
12. Alterations of blood glucose homeostasis in critically ill children - hyperglycemia.
Otto-Buczkowska E; Dworzecki T; Mazur U
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):43-6. PubMed ID: 17493406
[TBL] [Abstract][Full Text] [Related]
13. Effects of hyperglycemia and continuous intravenous insulin on outcomes of surgical patients.
Schlussel AT; Holt DB; Crawley EA; Lustik MB; Wade CE; Uyehara CF
J Surg Res; 2012 Jul; 176(1):202-9. PubMed ID: 21920548
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemic kidney damage in an animal model of prolonged critical illness.
Vanhorebeek I; Gunst J; Ellger B; Boussemaere M; Lerut E; Debaveye Y; Rabbani N; Thornalley PJ; Schetz M; Van den Berghe G
Kidney Int; 2009 Sep; 76(5):512-20. PubMed ID: 19536085
[TBL] [Abstract][Full Text] [Related]
15. Management of hyperglycemia in the pediatric intensive care unit; implementation of a glucose control protocol.
Verhoeven JJ; Brand JB; van de Polder MM; Joosten KF
Pediatr Crit Care Med; 2009 Nov; 10(6):648-52. PubMed ID: 19602994
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia is associated with poor outcomes in surgical critically ill patients receiving parenteral nutrition.
Yan CL; Huang YB; Chen CY; Huang GS; Yeh MK; Liaw WJ
Acta Anaesthesiol Taiwan; 2013 Jun; 51(2):67-72. PubMed ID: 23968657
[TBL] [Abstract][Full Text] [Related]
17. [Intensive insulin therapy in critically ill patients--pro].
Ellger B
Dtsch Med Wochenschr; 2006 Nov; 131(44):2480. PubMed ID: 17066359
[No Abstract] [Full Text] [Related]
18. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
[TBL] [Abstract][Full Text] [Related]
19. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.
Pittas AG; Siegel RD; Lau J
Arch Intern Med; 2004 Oct; 164(18):2005-11. PubMed ID: 15477435
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia in critically ill patients.
Knieriem M; Otto CM; Macintire D
Compend Contin Educ Vet; 2007 Jun; 29(6):360-2, 364-72; quiz 372. PubMed ID: 17724990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
